Abstract:MTOR (mechanistic target of rapamycin kinase) complex 1 (MTORC1) orchestrates diverse environmental signals to facilitate cell growth and is frequently activated in cancer. Translocation of MTORC1 from the cytosol to the lysosomal surface by the RRAG GTPases is the key step in MTORC1 activation. Here, we demonstrated that transcription factors MEF2A and MEF2D synergistically regulated MTORC1 activation via modulating its cyto-lysosome shutting. Mechanically, MEF2A and MEF2D controlled the transcription of FNIP1 and FNIP2, the components of the FLCN-FNIP1 or FNIP2 complex that acts as a RRAGC-RRAGD GTPase-activating element to promote the recruitment of MTORC1 to lysosome and its activation. Furthermore, we determined that the pro-oncogenic protein kinase SRC/c-Src directly phosphorylated MEF2D at three conserved tyrosine residues. The tyrosine phosphorylation enhanced MEF2D transcriptional activity and was indispensable for MTORC1 activation. Finally, both the protein and tyrosine phosphorylation levels of MEF2D are elevated in human pancreatic cancers, positively correlating with MTORC1 activity. Depletion of both MEF2A and MEF2D or expressing the unphosphorylatable MEF2D mutant suppressed tumor cell growth. Thus, our study revealed a transcriptional regulatory mechanism of MTORC1 that promoted cell anabolism and proliferation and uncovered its critical role in pancreatic cancer progression.Abbreviation: ACTB: actin beta; ChIP: chromatin immunoprecipitation; EGF: epidermal growth factor; EIF4EBP1: eukaryotic translation initiation factor 4E binding protein 1; FLCN: folliculin; FNIP1: folliculin interacting protein 1; FNIP2: folliculin interacting protein 2; GAP: GTPase activator protein; GEF: guanine nucleotide exchange factors; GTPase: guanosine triphosphatase; LAMP2: lysosomal associated membrane protein 2; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MEF2: myocyte enhancer factor 2; MEF2A: myocyte enhancer factor 2A; MEF2D: myocyte enhancer factor 2D; MEF2D-3YF: Y131F, Y333F, Y337F mutant; MTOR: mechanistic target of rapamycin kinase; MTORC1: MTOR complex 1; NR4A1: nuclear receptor subfamily 4 group A member 1; RPTOR: regulatory associated protein of MTOR complex 1; RHEB: Ras homolog, mTORC1 binding; RPS6KB1: ribosomal protein S6 kinase B1; RRAG: Ras related GTP binding; RT-qPCR: real time-quantitative PCR; SRC: SRC proto-oncogene, non-receptor tyrosine kinase; TMEM192: transmembrane protein 192; WT: wild-type.

Role of FLCN Phosphorylation in Insulin‐Mediated Mtorc1 Activation and Tumorigenesis

Direct Regulation of FNIP1 and FNIP2 by MEF2 Sustains MTORC1 Activation and Tumor Progression in Pancreatic Cancer.

Regulatory Function of Phosphorylation and Ubiquitination on The TORC1 Signaling Pathway

The Ubiquitination of Rag A GTPase by RNF152 Negatively Regulates Mtorc1 Activation.

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia.

Mtorc2 Mediate FLCN-induced HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma

FLCN Maintains the Leucine Level in Lysosome to Stimulate Mtorc1

FLCN Regulates HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma

RagC phosphorylation autoregulates mTOR complex 1

Post-translational Regulation of the Mtorc1 Pathway: A Switch That Regulates Metabolism-Related Gene Expression

Cystine Induced-mTORC2 Activation through Promoting Sin1 Phosphorylation to Suppress Cancer Cell Ferroptosis

Dual Phosphorylation of Sin1 at T86 and T398 Negatively Regulates Mtorc2 Complex Integrity and Activity

Current Models of Mammalian Target of Rapamycin Complex 1 (mtorc1) Activation by Growth Factors and Amino Acids

TRAF4‐Mediated LAMTOR1 Ubiquitination Promotes mTORC1 Activation and Inhibits the Inflammation‐Induced Colorectal Cancer Progression

PtdIns(3,4,5)P3-Dependent Activation of the Mtorc2 Kinase Complex

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT

Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells

The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1

Mtor Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer

The mammalian target of rapamycin pathway and its role in molecular nutrition regulation.